144 related articles for article (PubMed ID: 33041661)
21. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
22. SOX17 increases the cisplatin sensitivity of an endometrial cancer cell line.
Zhang Y; Jiang F; Bao W; Zhang H; He X; Wang H; Wan X
Cancer Cell Int; 2016; 16():29. PubMed ID: 27065754
[TBL] [Abstract][Full Text] [Related]
23. MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway.
Li Y; Zhang S; Wang Y; Peng J; Fang F; Yang X
BMC Cancer; 2018 Dec; 18(1):1294. PubMed ID: 30594176
[TBL] [Abstract][Full Text] [Related]
24. Silencing Bmi1 expression suppresses cancer stemness and enhances chemosensitivity in endometrial cancer cells.
Kim M; Lee S; Park WH; Suh DH; Kim K; Kim YB; No JH
Biomed Pharmacother; 2018 Dec; 108():584-589. PubMed ID: 30243092
[TBL] [Abstract][Full Text] [Related]
25. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
26. Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma.
Lu H; Ju DD; Yang GD; Zhu LY; Yang XM; Li J; Song WW; Wang JH; Zhang CC; Zhang ZG; Zhang R
EBioMedicine; 2019 Feb; 40():276-289. PubMed ID: 30594556
[TBL] [Abstract][Full Text] [Related]
27. Imatinib sensitizes endometrial cancer cells to cisplatin by targeting CD117-positive growth-competent cells.
Zhang X; Kyo S; Nakamura M; Mizumoto Y; Maida Y; Bono Y; Takakura M; Fujiwara H
Cancer Lett; 2014 Apr; 345(1):106-14. PubMed ID: 24333732
[TBL] [Abstract][Full Text] [Related]
28. Loss of AF-6/afadin induces cell invasion, suppresses the formation of glandular structures and might be a predictive marker of resistance to chemotherapy in endometrial cancer.
Yamamoto T; Mori T; Sawada M; Matsushima H; Ito F; Akiyama M; Kitawaki J
BMC Cancer; 2015 Apr; 15():275. PubMed ID: 25879875
[TBL] [Abstract][Full Text] [Related]
29. Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway.
Wu S; Zhang T; Du J
Drug Des Devel Ther; 2016; 10():3471-3481. PubMed ID: 27822011
[TBL] [Abstract][Full Text] [Related]
30. Nrf2 expression in endometrial serous carcinomas and its precancers.
Chen N; Yi X; Abushahin N; Pang S; Zhang D; Kong B; Zheng W
Int J Clin Exp Pathol; 2010 Dec; 4(1):85-96. PubMed ID: 21228930
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneous nuclear ribonucleoprotein C1 may control miR-30d levels in endometrial exosomes affecting early embryo implantation.
Balaguer N; Moreno I; Herrero M; González M; Simón C; Vilella F
Mol Hum Reprod; 2018 Aug; 24(8):411-425. PubMed ID: 29846695
[TBL] [Abstract][Full Text] [Related]
32. Nrf2 expression participates in growth and differentiation of endometrial carcinoma cells in vitro and in vivo.
Li K; Zhong C; Wang B; He J; Bi J
J Mol Histol; 2014 Apr; 45(2):161-7. PubMed ID: 24048968
[TBL] [Abstract][Full Text] [Related]
33. Normal endometrial stromal cells regulate survival and apoptosis signaling through PI3K/AKt/Survivin pathway in endometrial adenocarcinoma cells in vitro.
Shi M; Zhang H; Li M; Xue J; Fu Y; Yan L; Zhao X
Gynecol Oncol; 2011 Nov; 123(2):387-92. PubMed ID: 21794903
[TBL] [Abstract][Full Text] [Related]
34. Bladder cancer cells prevent cisplatin-induced oxidative stress by upregulating Nestin1 expression.
Zhang Y; Li Y
Am J Transl Res; 2021; 13(10):11178-11193. PubMed ID: 34786050
[TBL] [Abstract][Full Text] [Related]
35. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.
Wang XJ; Sun Z; Villeneuve NF; Zhang S; Zhao F; Li Y; Chen W; Yi X; Zheng W; Wondrak GT; Wong PK; Zhang DD
Carcinogenesis; 2008 Jun; 29(6):1235-43. PubMed ID: 18413364
[TBL] [Abstract][Full Text] [Related]
36. Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance.
Mirzaei S; Mohammadi AT; Gholami MH; Hashemi F; Zarrabi A; Zabolian A; Hushmandi K; Makvandi P; Samec M; Liskova A; Kubatka P; Nabavi N; Aref AR; Ashrafizadeh M; Khan H; Najafi M
Pharmacol Res; 2021 May; 167():105575. PubMed ID: 33771701
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer.
Ke J; Yang Y; Che Q; Jiang F; Wang H; Chen Z; Zhu M; Tong H; Zhang H; Yan X; Wang X; Wang F; Liu Y; Dai C; Wan X
Tumour Biol; 2016 Sep; 37(9):12203-12211. PubMed ID: 27230680
[TBL] [Abstract][Full Text] [Related]
38. Tumor-suppressor role of miR-139-5p in endometrial cancer.
Liu J; Li C; Jiang Y; Wan Y; Zhou S; Cheng W
Cancer Cell Int; 2018; 18():51. PubMed ID: 29618950
[TBL] [Abstract][Full Text] [Related]
39. [Study of claudin-4 in the diagnosis and treatment of endometrial carcinoma].
Pan XY; Li X; Che YC; Li X; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):768-71. PubMed ID: 24406135
[TBL] [Abstract][Full Text] [Related]
40. Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
Su J; Zhang F; Li X; Liu Z
Biochem Biophys Res Commun; 2019 Jun; 514(2):510-517. PubMed ID: 31056260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
